Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Round cell liposarcoma arising in the left foot: MRI and PET findings.

Kudo H, Inaoka T, Tokuyama W, Hiruta N, Nakagawa K, Hayashi A, Terada H.

Jpn J Radiol. 2012 Dec;30(10):852-7. doi: 10.1007/s11604-012-0119-y. Epub 2012 Sep 12.

PMID:
22965582
[PubMed - indexed for MEDLINE]
2.

Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.

Conill C, Setoain X, Colomo L, Palacín A, Combalia-Aleu A, Pomés J, Marruecos J, Vargas M, Maurel J.

J Magn Reson Imaging. 2008 Mar;27(3):625-8. doi: 10.1002/jmri.21298.

PMID:
18307201
[PubMed - indexed for MEDLINE]
3.

Metastatic myxoid liposarcomas: imaging and histopathologic findings.

Sheah K, Ouellette HA, Torriani M, Nielsen GP, Kattapuram S, Bredella MA.

Skeletal Radiol. 2008 Mar;37(3):251-8. Epub 2007 Dec 21.

PMID:
18097662
[PubMed - indexed for MEDLINE]
4.

Myxoid liposarcoma with negative features on bone scan and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography.

Sakamoto A, Fukutoku Y, Matsumoto Y, Harimaya K, Oda Y, Iwamoto Y.

World J Surg Oncol. 2012 Oct 9;10:214. doi: 10.1186/1477-7819-10-214.

PMID:
23046828
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.

Schwab JH, Boland PJ, Antonescu C, Bilsky MH, Healey JH.

Cancer. 2007 Oct 15;110(8):1815-22.

PMID:
17724681
[PubMed - indexed for MEDLINE]
Free Article
6.

Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.

Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, Uzan C, Lumbroso S, Lecuru F, Bats AS, Ghazzar N, Bannier M, Houvenaeghel G, Brenot-Rossi I, Narducci F.

Ann Surg Oncol. 2011 Aug;18(8):2302-9. doi: 10.1245/s10434-011-1583-9. Epub 2011 Feb 23.

PMID:
21347790
[PubMed - indexed for MEDLINE]
7.

Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.

Inubashiri E, Hata K, Kanenishi K, Shiota A, Ohno M, Yamamoto Y, Nishiyama Y, Ohkawa M, Hata T.

J Obstet Gynaecol Res. 2009 Feb;35(1):26-34. doi: 10.1111/j.1447-0756.2008.00832.x.

PMID:
19215544
[PubMed - indexed for MEDLINE]
8.

Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.

Yeh LS, Hung YC, Shen YY, Kao CH, Lin CC, Lee CC.

Oncol Rep. 2002 Nov-Dec;9(6):1289-92.

PMID:
12375036
[PubMed - indexed for MEDLINE]
9.

Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.

Tewfik JN, Greene GS.

Curr Probl Diagn Radiol. 2008 Jul-Aug;37(4):178-88. doi: 10.1067/j.cpradiol.2007.10.005. Review.

PMID:
18502325
[PubMed - indexed for MEDLINE]
10.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
11.

F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.

Wiesenthal AA, Nguyen BD.

Clin Nucl Med. 2007 Oct;32(10):797-801.

PMID:
17885362
[PubMed - indexed for MEDLINE]
12.

PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.

Suzuki R, Watanabe H, Yanagawa T, Sato J, Shinozaki T, Suzuki H, Endo K, Takagishi K.

Ann Nucl Med. 2005 Dec;19(8):661-70.

PMID:
16444991
[PubMed - indexed for MEDLINE]
13.

Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.

Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT.

J Clin Oncol. 2006 Sep 20;24(27):4371-6.

PMID:
16983105
[PubMed - indexed for MEDLINE]
14.

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Qu X, Huang X, Yan W, Wu L, Dai K.

Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26. Review.

PMID:
21354739
[PubMed - indexed for MEDLINE]
15.

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K.

J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi: 10.1093/jnci/djs188. Epub 2012 Apr 18.

PMID:
22517990
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.

Yanagawa T, Watanabe H, Inoue T, Ahmed AR, Tomiyoshi K, Shinozaki T, Oriuchi N, Endo K, Takagishi K.

J Comput Assist Tomogr. 2003 Mar-Apr;27(2):175-82.

PMID:
12703009
[PubMed - indexed for MEDLINE]
17.

Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

Yoon KT, Kim JK, Kim do Y, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.

Oncology. 2007;72 Suppl 1:104-10. Epub 2007 Dec 13.

PMID:
18087190
[PubMed - indexed for MEDLINE]
18.

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.

Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2007 Oct;43(9):887-93. Epub 2007 Jan 4.

PMID:
17207656
[PubMed - indexed for MEDLINE]
19.

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.

Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.

PMID:
21231796
[PubMed - indexed for MEDLINE]
20.

Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J.

Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.

PMID:
22772365
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk